Fig 7. Progression-free and overall survival for AT-101 monotherapy in patients with recurrent glioblastoma (NABTT 0702).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.